RHOA and fibrosarcoma: To experimentally verify this finding, we made use of previously established MAT systems in the fibrosarcoma cell line HT1080-doxycycline inducible expression of constitutively active RhoA (icaRhoA) and Src inhibitor dasatinib (DAS) treatment [32,33].